Amgen sends first KRAS drug to the FDA, approval could follow swiftly
It only took a decade or 3, but KRAS will finally have its day in court.
Amgen announced late Wednesday that they had submitted their …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
